Finally had a chance to go through the presentation. The good;FY...

Finally had a chance to go through the presentation.

The good;

• FY 25 guidance unchanged. Although net income guidance range is between $630m-$700m which could produce a big miss if JHX achieve on the lower end of guidance.
• Slight increase in gross margins.

The bad;

• Second quarter advised to be challenging despite Q2 apparently being a normally strong quarter (according to analysts at Jefferies).
• Slight decrease in EBIT margins.
• Growth is low single digits in some metrics, and declining in others.

I think it was a solid report considering all the macro, but I think the cautious outlook statement hasn't filled many with confidence. I thought I missed the opportunity to buy ~6 weeks ago when JHX jumped up to $55, but I think it will still linger around this price. An interest rate cut or two in the US will probably boost JHX slightly.

Did you end up buying some more @pastperformer ?

I think i'd be more comfortable jumping in at the low $40's, will it get there? who knows.